Skip to main content

Table 8 Mean (IU/L) ± standard deviation serum amylase and lipase values through Week 156

From: A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus

Week

Serum amylase

Serum lipase

Omarigliptin

N = 2092

Placebo

N = 2100

Omarigliptin

N = 2092

Placebo

N = 2100

0

66.5 ± 33.3

n = 1465

67.5 ± 39.2

n = 1457

45.1 ± 35.4

n = 1465

45.5 ± 53.5

n = 1457

6

71.3 ± 34.0

n = 1353

66.7 ± 35.1

n = 1338

53.4 ± 45.6

n = 1353

45.1 ± 50.1

n = 1337

12

72.9 ± 35.8

n = 1329

68.1 ± 42.7

n = 1301

56.2 ± 49.9

n = 1329

46.4 ± 41.7

n = 1300

18

71.6 ± 35.3

n = 1314

67.4 ± 35.2

n = 1281

52.1 ± 42.2

n = 1313

45.1 ± 39.0

n = 1280

24

72.0 ± 34.8

n = 1305

67.6 ± 33.4

n = 1296

55.6 ± 52.5

n = 1305

45.5 ± 35.0

n = 1295

32

71.3 ± 33.7

n = 1308

68.1 ± 34.8

n = 1292

51.4 ± 33.2

n = 1308

46.4 ± 42.9

n = 1292

40

70.9 ± 35.4

n = 1289

67.1 ± 33.8

n = 1261

51.3 ± 37.5

n = 1289

43.7 ± 29.3

n = 1261

48

71.6 ± 34.6

n = 1282

67.5 ± 35.9

n = 1235

54.2 ± 54.2

n = 1280

44.6 ± 36.1

n = 1236

54

74.1 ± 52.6

n = 1292

68.2 ± 33.5

n = 1253

56.3 ± 185.2

n = 1291

44.1 ± 37.9

n = 1253

66

72.8 ± 35.8

n = 1263

68.8 ± 42.4

n = 1229

54.3 ± 56.3

n = 1260

44.5 ± 37.1

n = 1229

78

75.1 ± 57.9

n = 1339

67.5 ± 33.9

n = 1297

53.4 ± 50.2

n = 1339

47.2 ± 61.9

n = 1294

90

72.1 ± 38.0

n = 836

69.1 ± 38.8

n = 808

57.4 ± 74.0

n = 835

46.1 ± 40.5

n = 808

104

74.8 ± 85.9

n = 612

68.3 ± 42.1

n = 568

72.3 ± 437.2

n = 611

45.1 ± 32.6

n = 568

116

74.7 ± 38.2

n = 376

65.5 ± 30.8

n = 351

59.0 ± 84.0

n = 376

46.6 ± 54.2

n = 351

128

75.7 ± 36.2

n = 213

64.1 ± 32.7

n = 223

58.4 ± 52.6

n = 213

42.9 ± 24.5

n = 223

142

70.7 ± 30.8

n = 69

71.7 ± 54.2

n = 55

52.8 ± 31.2

n = 69

44.0 ± 25.9

n = 55

156

70.0 ± N/A

n = 1

41.0 ± N/A

n = 1

31.0 ± N/A

n = 1

9.0 ± N/A

n = 1

  1. Measurement of amylase and lipase was added to the protocol after study initiation at the request of several European countries; therefore not all patients had baseline values
  2. Central laboratory normal range: serum amylase = 35–121 U/L; serum lipase = 13–60 U/L